There is growing pressure on EU policymakers to play a role in promoting the development of psychedelics as medicines. The pharmaceutical regulations reform is an opportunity to incentivise research say MEPs

The EDCTP partnership that sponsors clinical trials in Africa is a flagship of the EU’s health research effort. But as it reaches its 20 anniversary the pending pharmaceutical legislation and budget worries dog its future, warns Maria da Graça Carvalho MEP

Research commissioned by lobby group EFPIA shows Germany, Belgium and France will be among those hit hardest if the Commission’s proposals go ahead. In total, R&D would be cut by €2B per annum

The head of a biotech start-up tells how the war has upended his company and the wider Israeli ecosystem. The normal rules of capitalism have been relaxed, with rival start-ups and venture capitalists now helping each other out

Europe must give investors certainty by extending data protection for new drugs and facilitating access to market, says senior executive, as the industry continues to contest proposals for the largest reform of EU pharma legislation in over 20 years

Forty new rare disease programmes entering the clinic over the next decade. This is the goal of a new collaboration between Oxford University and the Harrington Discovery Institute, which aims to put up to £200M into getting projects out academic labs and into clinical development  

The role of science in informing policy has never been more explicit – or at times more controversial - than in the response to COVID-19. A new report examines the fallout and how the scientific advice system can be improved    

Researchers relieved after Commission says there is no need for a legislative proposal to reach the goal of phasing out the use of animals in research, but it will continue to fund the development of alternatives

Experts are calling for more regulatory action to bring precision medicine to the market, as big data enables more personalised treatments and prevention

The Commission is set to update legislation on genetic engineering of crops, with its proposal to be presented in July. There will be opposition from environmental groups that want the 2001 blanket ban to be retained